ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Integrated Transcriptomics and Proteomics Identified CMPK1 as a Potential Biomarker for Type 2 Diabetes Mellitus.

Kang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.